Brainstorm Cell Therapeutics Inc. Stock Forecast
Explanation to Bollinger's Bands
Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.
Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.
Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation
BandWidth defines the current width of the band.
%b defines the current position within the band.
BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)
Live Samples:
Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.
Source: http://www.bollingerbands.com
Big movements in Brainstorm Cell Therapeutics Inc. stock price on Wednesday moving 11.94% between high and low
(Updated on Apr 17, 2024)
The Brainstorm Cell Therapeutics Inc. stock price gained 2.60% on the last trading day (Wednesday, 17th Apr 2024), rising from $0.527 to $0.541. During the last trading day the stock fluctuated 11.94% from a day low at $0.525 to a day high of $0.588. The price has fallen in 6 of the last 10 days and is down by -21.54% for this period. Volume fell on the last day by -97 thousand shares and in total, 526 thousand shares were bought and sold for approximately $284.25 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 72.47% during the next 3 months and, with a 90% probability hold a price between $0.764 and $1.39 at the end of this 3-month period.
BCLI Signals & Forecast
A sell signal was issued from a pivot top point on Monday, April 01, 2024, and so far it has fallen -26.91%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not. Some positive signals were issued as well, and these may have some influence on the near short-term development. The Brainstorm Cell Therapeutics Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $0.566. On a fall, the stock will find some support from the long-term average at approximately $0.495. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal.
Support, Risk & Stop-loss for Brainstorm Cell Therapeutics Inc. stock
Brainstorm Cell Therapeutics Inc. finds support from accumulated volume at $0.527 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0627 between high and low, or 11.94%. For the last week the stock has had daily average volatility of 16.37%.
Our recommended stop-loss: $0.511 (-5.60%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 12 days ago.)
Trading Expectations (BCLI) For The Upcoming Trading Day Of Thursday 18th
For the upcoming trading day on Thursday, 18th we expect Brainstorm Cell Therapeutics Inc. to open at $0.551, and during the day (based on 14 day Average True Range), to move between $0.454 and $0.628, which gives a possible trading interval of +/-$0.0868 (+/-16.04%) up or down from last closing price. If Brainstorm Cell Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 32.09% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $0.527 (2.53%) than the resistance at $0.570 (5.40%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Brainstorm Cell Therapeutics Inc. stock A Buy?
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.
Current score: 3.255 Buy Candidate Unchanged
Predicted Opening Price for Brainstorm Cell Therapeutics Inc. of Thursday, April 18, 2024
Fair opening price April 18, 2024 | Current price |
---|---|
$0.551 ( 1.92%) | $0.541 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for BCLI
Fibonacci Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 0.614 | 13.51 % | |
R2 | 0.590 | 9.08 % | ||
R1 | 0.575 | 6.35 % | ||
Current price: | 0.541 | |||
Support | S1 | 0.527 | -2.51 % | |
S2 | 0.512 | -5.25 % | ||
S3 | 0.488 | -9.68 % |
Accumulated Volume Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 0.655 | 21.12 % | |
R2 | 0.583 | 7.71 % | ||
R1 | 0.570 | 5.40 % | ||
Current price | 0.541 | |||
Support | S1 | 0.527 | -2.53% | |
S2 | 0.507 | -6.25% | ||
S3 | 0.480 | -11.24% |
FAQ
Click here for our free guide on how to buy Brainstorm Cell Therapeutics Inc. Stock.